Inflammatory mediators and glucose in pregnancy: results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study.
about
The potential role of biomarkers in predicting gestational diabetesThe role of placental nutrient sensing in maternal-fetal resource allocationPerinatal depression--the fourth inflammatory morbidity of pregnancy?: Theory and literature reviewMaternal Microbiome and Pregnancy Outcomes That Impact Infant Health: A ReviewThe role of inflammatory pathway genetic variation on maternal metabolic phenotypes during pregnancyThe relationship and potential mechanistic pathways between sleep disturbances and maternal hyperglycemia.Correlation of disease severity with body weight and high fat diet in the FATZO/Pco mouse.Preterm birth and subsequent risk of type 2 diabetes in black womenAdiponectin and IGFBP-1 in the development of gestational diabetes in obese mothers.Inflammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus.First-trimester maternal serum C-reactive protein as a predictor of third-trimester impaired glucose toleranceEffect of maternal weight, adipokines, glucose intolerance and lipids on infant birth weight among women without gestational diabetes mellitus.Gestational diabetes mellitus and retinal microvasculature.Adiposity and Chronic Inflammation in Young Women Predict Inflammation during Normal Pregnancy in the PhilippinesEthnic Differences in Maternal Adipokines during Normal Pregnancy.Genetic Evidence for Causal Relationships Between Maternal Obesity-Related Traits and Birth Weight.Association between adiponectin and tumor necrosis factor-alpha levels at eight to fourteen weeks gestation and maternal glucose tolerance: the Parity, Inflammation, and Diabetes Study.Biological determinants linking infant weight gain and child obesity: current knowledge and future directions.Review: Adiponectin--the missing link between maternal adiposity, placental transport and fetal growth?Serum adiponectin levels in gestational diabetes mellitus.Genetics, genomics and metabolomics: new insights into maternal metabolism during pregnancy.Adiponectin inhibits insulin function in primary trophoblasts by PPARα-mediated ceramide synthesis.Intersection of complex genetic traits affecting maternal metabolism, fetal metabolism, and neural tube defect risk: looking for needles in multiple haystacks.The Relationship between Maternal Plasma Leptin and Adiponectin Concentrations and Newborn AdiposityRole of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases.Maternal pregnancy C-reactive protein predicts offspring birth size and body composition in metropolitan Cebu, Philippines.Genetics of Gestational Diabetes Mellitus and Maternal Metabolism.Maternal adipokines and insulin as biomarkers of pregnancies complicated by overweight and obesity.Lifetime Exposure to Intimate Partner Violence and Proinflammatory Cytokine Levels Across the Perinatal Period.Genetic determinants of adiponectin regulation revealed by pregnancy.Impact of lifestyle intervention for obese women during pregnancy on maternal metabolic and inflammatory markers.Maternal, umbilical arterial and umbilical venous 25-hydroxyvitamin D and adipocytokine concentrations in pregnancies with and without gestational diabetes.Optimal treatment of replicate measurements in anthropometric studies.Serum adiponectin in gestational diabetes and its relation to pregnancy outcome.Adipocytokines levels at delivery, functional variation of TFAP2β, and maternal and neonatal anthropometric parameters.Impact of Ramadan fasting on glucose levels in women with gestational diabetes mellitus treated with diet alone or diet plus metformin: a continuous glucose monitoring study.Gestational diabetes from A to Z.Controversies and Advances in Gestational Diabetes-An Update in the Era of Continuous Glucose Monitoring.A review of metabolic potential of human gut microbiome in human nutrition.The association between dysregulated adipocytokines in early pregnancy and development of gestational diabetes.
P2860
Q26739013-04E661DF-A533-48B3-8EBC-B17FB6691B37Q27008068-CAE6EDB5-ED37-4428-8A80-E9A7C67EF2F5Q27009185-ED59A117-DC5F-4243-A469-028B8645A5EAQ28085574-DD3815B2-A5AA-4FFC-90AF-7B633151248EQ28730838-F891314F-9C83-437B-B495-FFCC49630023Q33787121-A0761139-F193-49BC-8775-73CF05392073Q33825519-32608400-6BDB-40E2-9898-D1B22AA470E7Q34270460-7E386340-FBA0-4BDE-9833-3381195EA32BQ34419154-C8B6BE0A-38A0-4C25-B26C-D4D707B9B62EQ35814036-34788B36-2D30-4EBE-96DC-E22DCEE1133CQ35923904-B3587A20-31EF-4DD3-8135-19A56E8D4E83Q36247446-A6DEB1C5-C83B-4A5E-8B78-5F6A7BC50154Q36253044-A0E39051-1693-4046-9C39-9A292F6E7621Q36498062-F45B8791-06CD-4761-BF34-B9A639F800DBQ36512790-420093A7-1DEE-4EAD-8090-595270AE6369Q36738318-4B77052D-6787-4677-852C-7C411A2E4F34Q36789419-EC63C2B6-53CB-4219-B34E-B2A291B0DCB2Q36828825-37DA2669-DEF2-49B2-8713-82F739B49733Q36831805-7E9023E8-9A34-4D5C-9D68-053D27D5D99AQ37409096-AA8AC834-A664-4546-8B5D-A025A2A45BBBQ37589850-8133D9AB-6827-414B-AB2E-9F7EF002DE21Q37670103-FA85507E-D963-4DD3-9375-BE5A122FD328Q37695522-127228DD-CFA8-4000-A4E8-F826E015547DQ37729594-02F1F97C-CEE4-484B-A135-92FF5407D571Q38649391-C3ECB4E2-957C-47D8-AB92-A93F5002AEE1Q38673514-F7C8D879-AAC8-4DB3-AEBF-784D5FDE7112Q38709349-0D3AE96E-AA28-441E-868D-537B01D089FFQ39367987-87D0E288-0316-4344-A15C-45C37CFF4BF9Q40129829-BD34BC2D-68D7-4C3B-A09D-F8154F4F121BQ40285927-EB9511A6-9C42-468D-B3FF-B2524B619F77Q40378270-587469D7-A1FA-4F6B-A156-6CB28C331E3FQ43590275-E34C72C2-B0DD-4D9D-A314-5958D12F88ADQ44379198-E4F1D241-E976-4A23-9FE9-F6CD3FCF6D8DQ44435190-64D2A63E-7EF4-4E65-9CBA-3F93FAD4E522Q44582625-8FD90F88-09E5-4481-98B9-1AD3CABD4BD1Q47130846-5A941B2F-12CE-471B-827B-B9661EA4FE6AQ47155722-1414C5EE-64A9-42C0-9552-D9CCE8A8C696Q47712191-123535CD-4553-4775-86BD-B9F56704316AQ47810383-D7AC135D-77A0-4167-B207-46FAFCC45AB9Q47955677-A5DC151A-784A-4816-9A11-EA487012D931
P2860
Inflammatory mediators and glucose in pregnancy: results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inflammatory mediators and glu ...... regnancy Outcome (HAPO) Study.
@ast
Inflammatory mediators and glu ...... regnancy Outcome (HAPO) Study.
@en
Inflammatory mediators and glu ...... and Adverse Pregnancy Outcome
@nl
type
label
Inflammatory mediators and glu ...... regnancy Outcome (HAPO) Study.
@ast
Inflammatory mediators and glu ...... regnancy Outcome (HAPO) Study.
@en
Inflammatory mediators and glu ...... and Adverse Pregnancy Outcome
@nl
prefLabel
Inflammatory mediators and glu ...... regnancy Outcome (HAPO) Study.
@ast
Inflammatory mediators and glu ...... regnancy Outcome (HAPO) Study.
@en
Inflammatory mediators and glu ...... and Adverse Pregnancy Outcome
@nl
P2093
P2860
P356
P1476
Inflammatory mediators and glu ...... Pregnancy Outcome (HAPO) Study
@en
P2093
Alan R Dyer
Boyd E Metzger
HAPO Study Cooperative Research Group
Lynn P Lowe
Thomas W McDade
William L Lowe
P2860
P304
P356
10.1210/JC.2010-1662
P407
P577
2010-09-15T00:00:00Z